Ogilvie syndrome
Acute colonic pseudo-obstruction
| Ogilvie syndrome | |
|---|---|
| Synonyms | Acute colonic pseudo-obstruction |
| Pronounce | |
| Field | Gastroenterology, Surgery |
| Symptoms | Abdominal distension, pain, nausea, vomiting, constipation, absent bowel movements |
| Complications | Bowel ischemia, colonic perforation, sepsis |
| Onset | Sudden |
| Duration | Variable; can be acute or prolonged |
| Types | |
| Causes | Dysregulation of autonomic nervous system, often triggered by trauma, surgery, infection, or medications |
| Risks | Hospitalization, trauma, major surgery, electrolyte imbalances, use of opioids or anticholinergic medications |
| Diagnosis | Abdominal X-ray, CT scan, exclusion of mechanical obstruction |
| Differential diagnosis | Mechanical bowel obstruction, Toxic megacolon, Volvulus |
| Prevention | Minimize use of causative medications, early mobilization post-surgery |
| Treatment | Bowel rest, decompression with rectal tube or colonoscopy, neostigmine in refractory cases |
| Medication | Neostigmine (cholinesterase inhibitor) |
| Prognosis | Generally good with timely management; risk of complications if delayed |
| Frequency | Rare |
| Deaths | Associated with delayed diagnosis and complications such as perforation |
Ogilvie syndrome, also known as acute colonic pseudo-obstruction, is a condition characterized by the acute dilation of the colon in the absence of any mechanical obstruction. It is named after Sir William Heneage Ogilvie, who first described the syndrome in 1948.
Pathophysiology[edit]
Ogilvie syndrome is thought to result from an imbalance in the autonomic nervous system, which leads to a dysfunction in the colonic motility. The exact mechanism is not fully understood, but it is believed that there is an excessive sympathetic nervous system activity or a lack of parasympathetic activity, leading to colonic atony and dilation.
Causes[edit]
Ogilvie syndrome can occur in a variety of clinical settings. It is often associated with:
- Trauma
- Infection
- Surgery, particularly abdominal or pelvic surgery
- Neurological disorders such as Parkinson's disease or multiple sclerosis
- Electrolyte imbalances, such as hypokalemia or hypercalcemia
- Use of certain medications, including opioids and anticholinergics
Symptoms[edit]
The symptoms of Ogilvie syndrome are similar to those of a mechanical bowel obstruction and may include:
- Abdominal distension
- Abdominal pain
- Nausea and vomiting
- Constipation or inability to pass gas
Diagnosis[edit]
The diagnosis of Ogilvie syndrome is primarily clinical, supported by imaging studies. A plain abdominal X-ray or CT scan can show colonic dilation without evidence of mechanical obstruction. It is important to rule out true mechanical obstruction, which may require surgical intervention.
Treatment[edit]
The management of Ogilvie syndrome involves both conservative and pharmacological approaches:
Conservative Management[edit]
- Bowel rest and nasogastric decompression
- Correction of any underlying electrolyte imbalances
- Discontinuation of medications that may contribute to colonic atony
Pharmacological Treatment[edit]
- Administration of neostigmine, a cholinesterase inhibitor, can stimulate colonic motility and is often effective in resolving the condition.
Surgical Intervention[edit]
In cases where conservative and pharmacological treatments fail, or if there is evidence of colonic ischemia or perforation, surgical intervention may be necessary. This can include colonoscopy for decompression or, in severe cases, surgical resection of the affected bowel segment.
Prognosis[edit]
The prognosis of Ogilvie syndrome is generally good with appropriate treatment. However, if left untreated, it can lead to serious complications such as colonic perforation, peritonitis, and sepsis.
Related pages[edit]
External links[edit]
| Diseases of the human digestive system | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


